CohBar (NASDAQ:CWBR) is merging with privately held personalized cancer vaccine developer Morphogenesis and the combined company is expected to operate under the name TuHURA Biosciences Inc. Under the ...

TAMPA, Fla. (WFLA) – Tampa company Morphogenesis has received a “fast track” designation for its skin cancer vaccination from the United States Food and Drug Administration. Morphogenesis is a ...

A research team found that arginine metabolism has a vital role in regulating gametophore shoot formation in the moss Physcomitrium patens. Arginine metabolism boosts to make a plant body complex, ...

With the completion of the Anne T. and Robert M. Bass Biology Research Building at Stanford University, biology faculty and students who were once spread across campus were brought together under one ...

CohBar and Morphogenesis will morph into TuHURA Biosciences in an all-stock transaction that will see the newly formed, publicly held company work on addressing the major limitations of existing ...